These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3490739)

  • 1. Accumulation of a parkinsonism-inducing neurotoxin in melanin-bearing neurons: autoradiographic studies on 3H-MPTP.
    Lindquist NG; Lydén-Sokolowski A; Larsson BS
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):161-4. PubMed ID: 3490739
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sayre LM
    Toxicol Lett; 1989 Aug; 48(2):121-49. PubMed ID: 2672418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ; Lipman ZP; Snyder SH
    Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New clues to the etiology of Parkinson disease: parkinsonism induced by the neurotoxin MPTP].
    Jonsson G; Sundström E
    Lakartidningen; 1986 Jan; 83(4):215-8. PubMed ID: 3485230
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of 1-(3H)-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (3H-MPTP) in the frog: uptake in neuromelanin.
    Sokolowski AL; Larsson BS; Lindquist NG
    Pharmacol Toxicol; 1990 Apr; 66(4):252-8. PubMed ID: 2371232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain.
    Uhl GR; Javitch JA; Snyder SH
    Lancet; 1985 Apr; 1(8435):956-7. PubMed ID: 2859415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar distribution of monoamine oxidase (MAO) and parkinsonian toxin (MPTP) binding sites in human brain.
    Reznikoff G; Manaker S; Parsons B; Rhodes CH; Rainbow TC
    Neurology; 1985 Oct; 35(10):1415-9. PubMed ID: 3875804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.
    Speciale SG; Liang CL; Sonsalla PK; Edwards RH; German DC
    Neuroscience; 1998 Jun; 84(4):1177-85. PubMed ID: 9578404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on "Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)'.
    Di Monte D; Wu EY; Smith MT
    Toxicol Lett; 1989 Aug; 48(2):117-9. PubMed ID: 2788940
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.
    Javitch JA; Uhl GR; Snyder SH
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4591-5. PubMed ID: 6611553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin.
    Lindquist NG; Larsson BS; Lydén-Sokolowski A
    Neurosci Lett; 1988 Oct; 93(1):1-6. PubMed ID: 3264893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.
    Javitch JA; Snyder SH
    Eur J Pharmacol; 1984 Nov; 106(2):455-6. PubMed ID: 6335692
    [No Abstract]   [Full Text] [Related]  

  • 14. High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase.
    Parsons B; Rainbow TC
    Eur J Pharmacol; 1984 Jul; 102(2):375-7. PubMed ID: 6332739
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
    Hartvig P; Lindquist NG; Aquilonius SM; d'Argy R; Bergström K; Bondesson U; Eckernäs SA; Gullberg P; Larsson BS; Lindberg B
    Life Sci; 1986 Jan; 38(1):89-97. PubMed ID: 3484535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A
    FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y; Nagatsu T
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pethidine and parkinsonism. 1-Metyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a new neurotoxin].
    Hunskår S
    Tidsskr Nor Laegeforen; 1986 Jan; 106(3):219-20. PubMed ID: 3485316
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine.
    Moerlein SM; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
    Neurosci Lett; 1986 May; 66(2):205-9. PubMed ID: 3487753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S; Vincent SR
    Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.